Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 1071

Glucose oxidase enzyme preparation produced by Saccharomyces cerevisiae expressing a gene encoding a glucose oxidase from Aspergillus niger

Intended Use: Intended for use as an enzyme at up to 30.4 mg Total Organic Solids/kg flour in the manufacture of baked goods.
Basis: Scientific procedures
Notifier: Lallemand Inc.
Notifier Address: 1620 Prefontaine Street
Montreal, QC
H1W2N8
Canada
GRAS Notice (releasable information): GRN 1071 with amendment (in PDF) (2.8 MB)
Date of closure: Sep 28, 2023
FDA's Letter: FDA has no questions (in PDF) (169 kB)
-
-